3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion
Recruiting
Phase 4
Interventional Study
IUD
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 55
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 110 (estimated)
- Sponsor
- Women's College Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Intrauterine device (IUD) insertion is a common contraceptive procedure often associated with moderate to severe pain, particularly among nulliparous individuals. Current pain management strategies, such as over-the-counter analgesics, are frequently inadequate. Methoxyflurane, a short-acting, self-administered inhaled analgesic, has been shown to provide rapid and effective pain relief in acute a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients with a uterus.
2. Ages 18 to 55 years.
3. Undergoing any intrauterine device (IUD) insertion.
4. English-speaking participants.
5. Ability to use an inhaler device.
6. Willing to receive a cervical block for their IUD insertion
Exclusion Criteria:
1. Inability to p…
Contacts